Prestige Consumer Healthcare Inc. Long Term Debt

• Prestige Consumer Healthcare Inc. showed a decrease of -11.9% in Long Term Debt from 2024 to 2025.
• This data is from Prestige Consumer Healthcare Inc.'s annual report (Form 10-K), filed with the SEC on May 9, 2025.
• XBRL data for this metric is available from 2011 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2011: $464.17 million | Q3 2011: $447.40 million | Q4 2011: $429.63 million | Q2 2012: $1.10 billion | Q3 2012: $1.08 billion | Q4 2012: $1.00 billion | Q2 2013: $953.25 million | Q3 2013: $978.70 million | Q4 2013: $981.51 million | Q2 2014: $969.56 million | Q3 2014: $1.69 billion | Q4 2014: $1.64 billion | Q2 2015: $1.51 billion | Q3 2015: $1.47 billion | Q4 2015: $1.45 billion | Q2 2016: $1.58 billion | Q3 2016: $1.48 billion | Q4 2016: $1.42 billion | Q2 2017: $2.15 billion | Q3 2017: $2.09 billion | Q4 2017: $2.05 billion | Q2 2018: $1.99 billion | Q3 2018: $1.90 billion | Q4 2018: $1.84 billion | Q2 2019: $1.78 billion | Q3 2019: $1.75 billion | Q4 2019: $1.70 billion | Q2 2020: $1.62 billion | Q3 2020: $1.55 billion | Q4 2020: $1.55 billion | Q1 2021: $1.48 billion | Q2 2021: $1.55 billion | Q3 2021: $1.59 billion | Q4 2021: $1.53 billion | Q1 2022: $1.48 billion | Q2 2022: $1.47 billion | Q3 2022: $1.44 billion | Q4 2022: $1.42 billion | Q1 2023: $1.35 billion | Q2 2023: $1.32 billion | Q3 2023: $1.26 billion | Q4 2023: $1.20 billion | Q2 2024: $1.09 billion | Q3 2024: $1.05 billion | Q4 2024: $991.97 million | Q1 2025: $992.36 million | Q2 2025: $992.75 million | Q3 2025: $993.15 million | Q4 2025: $1.03 billion.
• Over the full 16 years of available data (2011 to 2025), Prestige Consumer Healthcare Inc.'s Long Term Debt has grown by 103.8%.
• Historical annual values: Fiscal year 2025: $992.36 million | Fiscal year 2024: $1.13 billion | Fiscal year 2024: $1.13 billion | Fiscal year 2023: $1.35 billion | Fiscal year 2022: $1.48 billion | Fiscal year 2021: $1.48 billion | Fiscal year 2020: $1.73 billion | Fiscal year 2019: $1.80 billion | Fiscal year 2018: $1.99 billion | Fiscal year 2017: $2.19 billion | Fiscal year 2016: $1.63 billion | Fiscal year 2015: $1.56 billion | Fiscal year 2014: $934.41 million | Fiscal year 2013: $970.90 million | Fiscal year 2012: $1.12 billion | Fiscal year 2011: $486.95 million.
• Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: August 8, 2026